Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Antibiotic misuse in respiratory tract infections in children and adults-a prospective, multicentre study (TAILORED Treatment).

van Houten CB, Cohen A, Engelhard D, Hays JP, Karlsson R, Moore E, Fernández D, Kreisberg R, Collins LV, de Waal W, de Winter-de Groot KM, Wolfs TFW, Meijers P, Luijk B, Oosterheert JJ, Heijligenberg R, Sankatsing SUC, Bossink AWJ, Stubbs A, Stein M, Reisfeld S, Klein A, Rachmilevitch R, Ashkar J, Braverman I, Kartun V, Chistyakov I, Bamberger E, Srugo I, Odeh M, Schiff E, Dotan Y, Boico O, Navon R, Friedman T, Etshtein L, Paz M, Gottlieb TM, Pri-Or E, Kronenfeld G, Simon E, Oved K, Eden E, Bont LJ.

Eur J Clin Microbiol Infect Dis. 2019 Mar;38(3):505-514. doi: 10.1007/s10096-018-03454-2. Epub 2019 Feb 1.

2.

Automating a new host-protein assay for differentiating bacterial from viral infection to reduce operator hands-on time.

Shapira M, Boico O, Cohen A, Sagi R, Aharon A, Navon R, Kronenfeld G, Maler K, Pri-Or E, Stein M, Klein A, Eden E, Oved K.

Biotechniques. 2018 Aug;65(2):93-95. doi: 10.2144/btn-2018-0028.

3.

A host-protein signature is superior to other biomarkers for differentiating between bacterial and viral disease in patients with respiratory infection and fever without source: a prospective observational study.

Ashkenazi-Hoffnung L, Oved K, Navon R, Friedman T, Boico O, Paz M, Kronenfeld G, Etshtein L, Cohen A, Gottlieb TM, Eden E, Chistyakov I, Srugo I, Klein A, Ashkenazi S, Scheuerman O.

Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1361-1371. doi: 10.1007/s10096-018-3261-3. Epub 2018 Apr 26.

4.

A novel host-protein assay outperforms routine parameters for distinguishing between bacterial and viral lower respiratory tract infections.

Stein M, Lipman-Arens S, Oved K, Cohen A, Bamberger E, Navon R, Boico O, Friedman T, Etshtein L, Paz M, Gottlieb TM, Kriger O, Fonar Y, Pri-Or E, Yacobov R, Dotan Y, Hochberg A, Grupper M, Chistyakov I, Potasman I, Srugo I, Eden E, Klein A.

Diagn Microbiol Infect Dis. 2018 Mar;90(3):206-213. doi: 10.1016/j.diagmicrobio.2017.11.011. Epub 2017 Nov 24.

PMID:
29273482
5.

Validation of a Novel Assay to Distinguish Bacterial and Viral Infections.

Srugo I, Klein A, Stein M, Golan-Shany O, Kerem N, Chistyakov I, Genizi J, Glazer O, Yaniv L, German A, Miron D, Shachor-Meyouhas Y, Bamberger E, Oved K, Gottlieb TM, Navon R, Paz M, Etshtein L, Boico O, Kronenfeld G, Eden E, Cohen R, Chappuy H, Angoulvant F, Lacroix L, Gervaix A.

Pediatrics. 2017 Oct;140(4). pii: e20163453. doi: 10.1542/peds.2016-3453. Epub 2017 Sep 13.

6.

Non-Small-cell Lung Cancer Patients With Adenocarcinoma Morphology Have a Better Outcome Compared With Patients Diagnosed With Non-Small-cell Lung Cancer Favor Adenocarcinoma.

Shiran I, Heller E, Jessel S, Kamer I, Daniel-Meshulam I, Navon R, Urban D, Onn A, Bar J.

Clin Lung Cancer. 2017 May;18(3):316-323.e1. doi: 10.1016/j.cllc.2017.01.009. Epub 2017 Feb 2.

PMID:
28237243
7.

Diagnostic accuracy of a TRAIL, IP-10 and CRP combination for discriminating bacterial and viral etiologies at the Emergency Department.

Eden E, Srugo I, Gottlieb T, Navon R, Boico O, Cohen A, Bamberger E, Klein A, Oved K.

J Infect. 2016 Aug;73(2):177-80. doi: 10.1016/j.jinf.2016.05.002. Epub 2016 May 30. No abstract available.

8.

Effect of cyclic, low dose pyrimethamine treatment in patients with Late Onset Tay Sachs: an open label, extended pilot study.

Osher E, Fattal-Valevski A, Sagie L, Urshanski N, Sagiv N, Peleg L, Lerman-Sagie T, Zimran A, Elstein D, Navon R, Valevski A, Stern N.

Orphanet J Rare Dis. 2015 Apr 17;10:45. doi: 10.1186/s13023-015-0260-7.

9.

A novel host-proteome signature for distinguishing between acute bacterial and viral infections.

Oved K, Cohen A, Boico O, Navon R, Friedman T, Etshtein L, Kriger O, Bamberger E, Fonar Y, Yacobov R, Wolchinsky R, Denkberg G, Dotan Y, Hochberg A, Reiter Y, Grupper M, Srugo I, Feigin P, Gorfine M, Chistyakov I, Dagan R, Klein A, Potasman I, Eden E.

PLoS One. 2015 Mar 18;10(3):e0120012. doi: 10.1371/journal.pone.0120012. eCollection 2015.

10.

Preferences for disclosure of disease related information among thoracic cancer patients.

Sella T, Botser D, Navon R, Biran H, Tenenbaum S, Urban D, Onn A, Bar J.

Lung Cancer. 2015 Apr;88(1):100-3. doi: 10.1016/j.lungcan.2015.01.021. Epub 2015 Jan 31.

PMID:
25682317
11.

ENViz: a Cytoscape App for integrated statistical analysis and visualization of sample-matched data with multiple data types.

Steinfeld I, Navon R, Creech ML, Yakhini Z, Tsalenko A.

Bioinformatics. 2015 May 15;31(10):1683-5. doi: 10.1093/bioinformatics/btu853. Epub 2015 Jan 9.

12.

MicroRNA-382 expression is elevated in the olfactory neuroepithelium of schizophrenia patients.

Mor E, Kano S, Colantuoni C, Sawa A, Navon R, Shomron N.

Neurobiol Dis. 2013 Jul;55:1-10. doi: 10.1016/j.nbd.2013.03.011. Epub 2013 Mar 29.

13.

miRNA target enrichment analysis reveals directly active miRNAs in health and disease.

Steinfeld I, Navon R, Ach R, Yakhini Z.

Nucleic Acids Res. 2013 Feb 1;41(3):e45. doi: 10.1093/nar/gks1142. Epub 2012 Dec 2.

14.

Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor.

Zehavi L, Avraham R, Barzilai A, Bar-Ilan D, Navon R, Sidi Y, Avni D, Leibowitz-Amit R.

Mol Cancer. 2012 Jul 2;11:44.

15.

Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression.

Pareja F, Ferraro DA, Rubin C, Cohen-Dvashi H, Zhang F, Aulmann S, Ben-Chetrit N, Pines G, Navon R, Crosetto N, Köstler W, Carvalho S, Lavi S, Schmitt F, Dikic I, Yakhini Z, Sinn P, Mills GB, Yarden Y.

Oncogene. 2012 Oct 25;31(43):4599-608. doi: 10.1038/onc.2011.587. Epub 2011 Dec 19.

16.

Deregulation of the A-to-I RNA editing mechanism in psychiatric disorders.

Silberberg G, Lundin D, Navon R, Öhman M.

Hum Mol Genet. 2012 Jan 15;21(2):311-21. doi: 10.1093/hmg/ddr461. Epub 2011 Oct 7.

PMID:
21984433
17.

Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue.

Borgan E, Navon R, Vollan HK, Schlichting E, Sauer T, Yakhini Z, Lingjærde OC, Sørlie T, Børresen-Dale AL.

Mol Oncol. 2011 Dec;5(6):564-76. doi: 10.1016/j.molonc.2011.08.004. Epub 2011 Aug 29.

18.

Interactions of carbamazepine in soil: effects of dissolved organic matter.

Navon R, Hernandez-Ruiz S, Chorover J, Chefetz B.

J Environ Qual. 2011 May-Jun;40(3):942-8. doi: 10.2134/jeq2010.0446.

PMID:
21546680
19.

miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors.

Enerly E, Steinfeld I, Kleivi K, Leivonen SK, Aure MR, Russnes HG, Rønneberg JA, Johnsen H, Navon R, Rødland E, Mäkelä R, Naume B, Perälä M, Kallioniemi O, Kristensen VN, Yakhini Z, Børresen-Dale AL.

PLoS One. 2011 Feb 22;6(2):e16915. doi: 10.1371/journal.pone.0016915.

20.

Pyrimethamine increases β-hexosaminidase A activity in patients with Late Onset Tay Sachs.

Osher E, Fattal-Valevski A, Sagie L, Urshanski N, Amir-Levi Y, Katzburg S, Peleg L, Lerman-Sagie T, Zimran A, Elstein D, Navon R, Stern N, Valevski A.

Mol Genet Metab. 2011 Mar;102(3):356-63. doi: 10.1016/j.ymgme.2010.11.163. Epub 2010 Dec 4.

PMID:
21185210
21.

Genetic analysis of nitric oxide synthase 1 variants in schizophrenia and bipolar disorder.

Silberberg G, Ben-Shachar D, Navon R.

Am J Med Genet B Neuropsychiatr Genet. 2010 Oct 5;153B(7):1318-28. doi: 10.1002/ajmg.b.31112.

PMID:
20645313
22.

Two novel exonic point mutations in HEXA identified in a juvenile Tay-Sachs patient: role of alternative splicing and nonsense-mediated mRNA decay.

Levit A, Nutman D, Osher E, Kamhi E, Navon R.

Mol Genet Metab. 2010 Jun;100(2):176-83. doi: 10.1016/j.ymgme.2010.03.010. Epub 2010 Mar 19.

PMID:
20363167
23.

A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype.

Buganim Y, Goldstein I, Lipson D, Milyavsky M, Polak-Charcon S, Mardoukh C, Solomon H, Kalo E, Madar S, Brosh R, Perelman M, Navon R, Goldfinger N, Barshack I, Yakhini Z, Rotter V.

PLoS One. 2010 Mar 11;5(3):e9657. doi: 10.1371/journal.pone.0009657.

24.

Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types.

Navon R, Wang H, Steinfeld I, Tsalenko A, Ben-Dor A, Yakhini Z.

PLoS One. 2009 Nov 25;4(11):e8003. doi: 10.1371/journal.pone.0008003.

25.

Detection of stable reference genes for real-time PCR analysis in schizophrenia and bipolar disorder.

Silberberg G, Baruch K, Navon R.

Anal Biochem. 2009 Aug 15;391(2):91-7. doi: 10.1016/j.ab.2009.05.026. Epub 2009 May 21.

PMID:
19464249
26.

GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists.

Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z.

BMC Bioinformatics. 2009 Feb 3;10:48. doi: 10.1186/1471-2105-10-48.

27.

Association between golli-MBP and schizophrenia in the Jewish Ashkenazi population: are regulatory regions involved?

Baruch K, Silberberg G, Aviv A, Shamir E, Bening-Abu-Shach U, Baruch Y, Darvasi A, Navon R.

Int J Neuropsychopharmacol. 2009 Aug;12(7):885-94. doi: 10.1017/S1461145708009887. Epub 2009 Jan 21.

28.

Clinically driven semi-supervised class discovery in gene expression data.

Steinfeld I, Navon R, Ardigò D, Zavaroni I, Yakhini Z.

Bioinformatics. 2008 Aug 15;24(16):i90-7. doi: 10.1093/bioinformatics/btn279.

PMID:
18689846
29.

Interactions of hydrophobic fractions of dissolved organic matter with Fe(3+) - and Cu(2+)-montmorillonite.

Polubesova T, Chen Y, Navon R, Chefetz B.

Environ Sci Technol. 2008 Jul 1;42(13):4797-803.

PMID:
18678008
30.

Neurocognitive testing in late-onset Tay-Sachs disease: a pilot study.

Elstein D, Doniger GM, Simon E, Korn-Lubetzki I, Navon R, Zimran A.

J Inherit Metab Dis. 2008 Aug;31(4):518-23. doi: 10.1007/s10545-008-0884-z. Epub 2008 May 30.

PMID:
18618288
31.

Stargazin involvement with bipolar disorder and response to lithium treatment.

Silberberg G, Levit A, Collier D, St Clair D, Munro J, Kerwin RW, Tondo L, Floris G, Breen G, Navon R.

Pharmacogenet Genomics. 2008 May;18(5):403-12. doi: 10.1097/FPC.0b013e3282f974ca.

PMID:
18408563
32.

Chromosome 10q harbors a susceptibility locus for bipolar disorder in Ashkenazi Jewish families.

Venken T, Alaerts M, Souery D, Goossens D, Sluijs S, Navon R, Van Broeckhoven C, Mendlewicz J, Del-Favero J, Claes S.

Mol Psychiatry. 2008 Apr;13(4):442-50. Epub 2007 Jun 19.

PMID:
17579605
33.

A complete genetic association scan of the 22q11 deletion region and functional evidence reveal an association between DGCR2 and schizophrenia.

Shifman S, Levit A, Chen ML, Chen CH, Bronstein M, Weizman A, Yakir B, Navon R, Darvasi A.

Hum Genet. 2006 Sep;120(2):160-70. Epub 2006 Jun 17.

PMID:
16783572
34.

The involvement of ErbB4 with schizophrenia: association and expression studies.

Silberberg G, Darvasi A, Pinkas-Kramarski R, Navon R.

Am J Med Genet B Neuropsychiatr Genet. 2006 Mar 5;141B(2):142-8.

PMID:
16402353
35.

Transmission disequilibrium and haplotype analyses of the G72/G30 locus: suggestive linkage to schizophrenia in Palestinian Arabs living in the North of Israel.

Korostishevsky M, Kremer I, Kaganovich M, Cholostoy A, Murad I, Muhaheed M, Bannoura I, Rietschel M, Dobrusin M, Bening-Abu-Shach U, Belmaker RH, Maier W, Ebstein RP, Navon R.

Am J Med Genet B Neuropsychiatr Genet. 2006 Jan 5;141B(1):91-5.

PMID:
16082701
36.

Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review.

Thakkinstian A, McEvoy M, Minelli C, Gibson P, Hancox B, Duffy D, Thompson J, Hall I, Kaufman J, Leung TF, Helms PJ, Hakonarson H, Halpi E, Navon R, Attia J.

Am J Epidemiol. 2005 Aug 1;162(3):201-11. Epub 2005 Jun 29. Review.

PMID:
15987731
37.

Is the G72/G30 locus associated with schizophrenia? single nucleotide polymorphisms, haplotypes, and gene expression analysis.

Korostishevsky M, Kaganovich M, Cholostoy A, Ashkenazi M, Ratner Y, Dahary D, Bernstein J, Bening-Abu-Shach U, Ben-Asher E, Lancet D, Ritsner M, Navon R.

Biol Psychiatry. 2004 Aug 1;56(3):169-76.

PMID:
15271585
38.

Is the WKL1 gene associated with schizophrenia?

Kaganovich M, Peretz A, Ritsner M, Bening Abu-Shach U, Attali B, Navon R.

Am J Med Genet B Neuropsychiatr Genet. 2004 Feb 15;125B(1):31-7.

PMID:
14755440
39.

A locus for complicated hereditary spastic paraplegia maps to chromosome 1q24-q32.

Blumen SC, Bevan S, Abu-Mouch S, Negus D, Kahana M, Inzelberg R, Mazarib A, Mahamid A, Carasso RL, Slor H, Withers D, Nisipeanu P, Navon R, Reid E.

Ann Neurol. 2003 Dec;54(6):796-803.

PMID:
14681889
40.

Genetic polymorphisms of the beta-2 adrenergic receptor in Israelis with severe asthma compared to non-asthmatic Israelis.

Shachor J, Chana Z, Varsano S, Erlich T, Goldman E, Dror Y, Yakovy I, Navon R.

Isr Med Assoc J. 2003 Nov;5(11):821-4.

41.

Association study of CAG repeats in the KCNN3 gene in Israeli patients with major psychosis.

Ritsner M, Amir S, Koronyo-Hamaoui M, Gak E, Ziv H, Halperin T, Kitain L, Navon R.

Psychiatr Genet. 2003 Sep;13(3):143-50.

PMID:
12960745
42.

An association of CAG repeats at the KCNN3 locus with symptom dimensions of schizophrenia.

Ritsner M, Modai I, Ziv H, Amir S, Halperin T, Weizman A, Navon R.

Biol Psychiatry. 2002 May 15;51(10):788-94.

PMID:
12007452
43.

Late-onset GM2 gangliosidosis and other hexosaminidase mutations among Jews.

Navon R.

Adv Genet. 2001;44:185-97. Review. No abstract available.

PMID:
11596983
44.

31Phosphorus magnetic resonance spectroscopy in late-onset Tay-Sachs disease.

Felderhoff-Mueser U, Sperner J, Konstanzcak P, Navon R, Weschke B.

J Child Neurol. 2001 May;16(5):377-80.

PMID:
11392526
45.

Growth failure associated with the use of high dose prozac (fluoxetine hydrochloride) in a patient with type 1 diabetes mellitus.

Frank GR, Navon RE.

J Pediatr Endocrinol Metab. 1999 May-Jun;12(3):467-9. No abstract available.

PMID:
10821228
46.

hKCa3/KCNN3 potassium channel gene: association of longer CAG repeats with schizophrenia in Israeli Ashkenazi Jews, expression in human tissues and localization to chromosome 1q21.

Dror V, Shamir E, Ghanshani S, Kimhi R, Swartz M, Barak Y, Weizman R, Avivi L, Litmanovitch T, Fantino E, Kalman K, Jones EG, Chandy KG, Gargus JJ, Gutman GA, Navon R.

Mol Psychiatry. 1999 May;4(3):254-60.

47.
48.

Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.

Horowitz M, Pasmanik-Chor M, Borochowitz Z, Falik-Zaccai T, Heldmann K, Carmi R, Parvari R, Beit-Or H, Goldman B, Peleg L, Levy-Lahad E, Renbaum P, Legum S, Shomrat R, Yeger H, Benbenisti D, Navon R, Dror V, Shohat M, Magal N, Navot N, Eyal N.

Hum Mutat. 1998;12(4):240-4. Erratum in: Hum Mutat 1999;13(3):255.

PMID:
9744474
49.

Juvenile-onset spinal muscular atrophy caused by compound heterozygosity for mutations in the HEXA gene.

Navon R, Khosravi R, Melki J, Drucker L, Fontaine B, Turpin JC, N'Guyen B, Fardeau M, Rondot P, Baumann N.

Ann Neurol. 1997 May;41(5):631-8.

PMID:
9153525
50.

[Juvenile GM2 gangliosidosis with progressive spinal muscular atrophy onset].

Rondot P, Navon R, Eymard B, Fardeau M, Turpin JC, Lefevre M, Bathien N, Wu Y, Baumann N.

Rev Neurol (Paris). 1997 Mar;153(2):120-3. French.

PMID:
9296123

Supplemental Content

Support Center